acquired
Stage
About
IntegerBio, Inc develops broad therapeutics combining immunology and virology science to create durable treatments targeting multiple viruses.
Explore IntegerBio, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.